Meriem Bensalem Owen — University of Kentucky

Education/Academic qualification

Post Doctoral Fellow, University Of Michigan-Ann Arbor

2004

Residency, University Of Kentucky

2003

Doctor of Medicine, University Of Algiers

1996

6 Active
44 Finished

A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Adults Diagnosed With Epilepsy (X-TOLE4)
Bensalem Owen, M.
Xenon Pharmaceuticals Incorporated
10/10/23 → 10/10/25
Project: Research project
X-ACKT_XPF-010-303: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Bensalem Owen, M.
Xenon Pharmaceuticals Incorporated
8/9/23 → 8/9/25
Project: Research project
EP0165: AN Open-Label, Multicenter, Outpatient Extension Study To Evaluate The Safety and Tolerability of Staccato Alprazolam In Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures
Bensalem Owen, M.
UCB Pharma (domestic)
8/2/23 → 8/2/25
Project: Research project
X-TOLE2_XPF-010-301: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
Bensalem Owen, M.
Xenon Pharmaceuticals Incorporated
7/24/23 → 7/24/25
Project: Research project
EP0162: A Double-blind, Randomized, Placebo-controled, Multicenter, Outpatient, Parallel-group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures
Bensalem Owen, M.
UCB Pharma (domestic)
6/20/23 → 6/20/25
Project: Research project